Patents Assigned to Hepanova, Inc.
  • Amino-aryl-benzamide compounds and methods of use thereof
    Patent number: 12053443
    Abstract: A method for the treatment and/or reduction of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) is disclosed. The method uses active amino-aryl-benzamide compounds and methods for the preparation thereof.
    Type: Grant
    Filed: April 16, 2021
    Date of Patent: August 6, 2024
    Assignee: Hepanova, Inc.
    Inventors: Ke Li, Belle Xiaohong Wang, Yongmei Li, Qiong Li
  • Amino-aryl-benzamide compounds and methods of use thereof
    Patent number: 11000491
    Abstract: A method for the treatment and/or reduction of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) is disclosed. The method uses active amino-aryl-benzamide compounds and methods for the preparation thereof.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: May 11, 2021
    Assignee: Hepanova, Inc.
    Inventors: Ke Li, Belle Xiaohong Wang, Yongmei Li, Qiong Li